biote Corp. Director Departs, New Director Appointed
Ticker: BTMD · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1819253
Sentiment: neutral
Topics: board-changes, executive-compensation
TL;DR
biote Corp. board shakeup: Cohen out, Katz in. Details on exec pay also filed.
AI Summary
On April 22, 2025, biote Corp. announced the departure of Director Jonathan B. Cohen and the appointment of Dr. David L. Katz as a new director. The company also reported on compensatory arrangements for its named executive officers, though specific financial details were not provided in this excerpt.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns board and officer changes and compensatory arrangements, which are routine disclosures and do not inherently indicate significant financial risk.
Key Players & Entities
- biote Corp. (company) — Registrant
- Jonathan B. Cohen (person) — Departing Director
- Dr. David L. Katz (person) — Appointed Director
- Haymaker Acquisition Corp. III (company) — Former Company Name
FAQ
Who has departed from the biote Corp. board of directors?
Jonathan B. Cohen has departed from the biote Corp. board of directors.
Who has been appointed as a new director to biote Corp.'s board?
Dr. David L. Katz has been appointed as a new director to biote Corp.'s board.
What is the principal executive office address for biote Corp.?
The principal executive office address for biote Corp. is 1875 W. Walnut Hill Ln #100, Irving, Texas 75038.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 22, 2025.
What was biote Corp.'s former company name?
biote Corp.'s former company name was Haymaker Acquisition Corp. III.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 by Jonathan B. Cohen regarding biote Corp. (BTMD).